Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primidone for acute cerebral ischemic stroke
ChiCTR2400079901Phase 2Not yet recruiting
- Sponsor
- Yichang First People's Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of primidone in ischemic stroke (2 arms), sponsored by Yichang First People's Hospital. Primary endpoints: Modified Rankin Scale score, National Institutes of Health Stroke Scale score and 2 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
primidone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400079901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079901.